BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

14 hedge funds and large institutions have $2.81M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.01M
2 +$535K

Top Sellers

1 -$480K
2 -$42.6K
3 -$21.9K
4
UBS Group
UBS Group
Switzerland
-$20.3K
5
Comerica Bank
Comerica Bank
Texas
-$6.26K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.01M
2
$847K
3
$538K
4
$321K
5
$25.3K
6
$21.2K
7
$20K
8
$11.3K
9
$7.83K
10
$2.53K
11
$1.11K
12
$884
13
$278
14
$126
15
16
17
18